(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 42.99%388.8M | 15.80%1.46B | 3.13%335.7M | 6.07%496.2M | 48.28%358.4M | 19.41%271.9M | 6.77%1.26B | 0.74%325.5M | 27.05%467.8M | 5.22%241.7M |
Net income from continuing operations | 47.67%167.6M | 6.44%635.1M | -0.91%141.2M | 15.65%209.1M | 9.60%171.3M | -3.07%113.5M | 1.41%596.7M | -13.37%142.5M | 0.89%180.8M | 25.34%156.3M |
Operating gains losses | -184.48%-9.8M | -86.77%2.5M | -48.78%8.4M | -113.89%-15.4M | -184.00%-2.1M | --11.6M | 197.42%18.9M | 4,200.00%16.4M | ---7.2M | 109.26%2.5M |
Depreciation and amortization | 25.31%236.2M | 18.41%909M | 21.70%231.1M | 24.70%238.8M | 30.79%250.6M | -3.18%188.5M | -2.05%767.7M | -3.90%189.9M | -1.44%191.5M | -2.54%191.6M |
Asset impairment expenditure | --2.4M | 129.73%8.5M | -44.44%500K | 185.71%8M | ---- | --0 | 146.67%3.7M | 28.57%900K | --2.8M | ---- |
Unrealized gains and losses of investment securities | --0 | -150.00%-400K | ---100K | -160.00%-300K | 50.00%300K | -104.11%-300K | 105.56%800K | --0 | 108.33%500K | -60.00%200K |
Deferred tax | -28.84%-27.7M | 110.58%6.7M | 227.36%13.5M | 263.64%14.4M | 102.13%300K | 27.85%-21.5M | -5.68%-63.3M | -17.78%-10.6M | -27.54%-8.8M | 42.68%-14.1M |
Other non cashItems | 275.00%3M | 661.54%9.9M | 64.71%-1.2M | 72.50%6.9M | 383.33%3.4M | -57.89%800K | -98.55%1.3M | -217.24%-3.4M | 81.82%4M | -101.45%-1.2M |
Change In working capital | 182.61%17.1M | -72.90%-109.1M | -465.69%-57.7M | -66.70%34.7M | 30.13%-65.4M | 67.40%-20.7M | 66.27%-63.1M | 60.77%-10.2M | 1,829.63%104.2M | 24.09%-93.6M |
-Change in receivables | ---- | -1,716.67%-141.7M | ---- | ---- | ---- | ---- | 93.32%-7.8M | ---- | ---- | ---- |
-Change in inventory | ---- | 81.39%-25.8M | ---- | ---- | ---- | ---- | -195.52%-138.6M | ---- | ---- | ---- |
-Change in payables and accrued expense | ---- | 7.16%86.8M | ---- | ---- | ---- | ---- | 244.68%81M | ---- | ---- | ---- |
-Change in other working capital | ---- | -1,334.78%-28.4M | ---- | ---- | ---- | ---- | 104.89%2.3M | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 42.99%388.8M | 15.80%1.46B | 3.13%335.7M | 6.07%496.2M | 48.28%358.4M | 19.41%271.9M | 6.77%1.26B | 0.74%325.5M | 27.05%467.8M | 5.22%241.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -31.02%-203.6M | -324.12%-2.68B | -25.70%-151.6M | 14.33%-150M | -1,160.93%-2.22B | 2.57%-155.4M | 54.06%-631.3M | 86.65%-120.6M | 45.94%-175.1M | -2.86%-176.1M |
Net PPE purchase and sale | 17.81%-90M | 15.80%-436.3M | -13.49%-112.7M | 28.18%-101.7M | 25.22%-112.4M | 13.78%-109.5M | -94.16%-518.2M | 24.49%-99.3M | -13.83%-141.6M | -36.76%-150.3M |
Net intangibles purchas and sale | -117.11%-99M | -81.95%-166.3M | -79.55%-39.5M | -176.58%-43.7M | -57.56%-37.5M | -53.02%-45.6M | 91.03%-91.4M | 96.88%-22M | 92.23%-15.8M | 52.78%-23.8M |
Net business purchase and sale | ---- | -9,264.71%-2.07B | --0 | 90.16%-1.8M | -54,315.79%-2.07B | ---- | -5.24%-22.1M | --0 | -2,387.50%-18.3M | 43.28%-3.8M |
Net investment purchase and sale | -2,333.33%-14.6M | -6.06%-7M | -250.00%-300K | -600.00%-2.8M | -43.48%-3.3M | 85.37%-600K | 91.22%-6.6M | 100.30%200K | ---400K | 68.06%-2.3M |
Net other investing changes | ---- | -75.71%1.7M | 80.00%900K | ---- | -87.80%500K | -78.57%300K | -9.09%7M | -66.67%500K | -67.74%1M | 36.67%4.1M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -31.02%-203.6M | -324.12%-2.68B | -25.70%-151.6M | 14.33%-150M | -1,160.93%-2.22B | 2.57%-155.4M | 54.06%-631.3M | 86.65%-120.6M | 45.94%-175.1M | -2.86%-176.1M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 2.77%-133.4M | 245.27%1.18B | 22.22%-198.1M | -21.53%-353.3M | 1,543.32%1.87B | 0.36%-137.2M | -388.26%-812.6M | -304.91%-254.7M | 81.45%-290.7M | -111.00%-129.5M |
Net issuance payments of debt | 69.98%-133.4M | 498.62%1.16B | 15.33%-128.1M | -99.42%-277M | 1,705.58%2.01B | -298.12%-444.3M | -144.82%-290.6M | -161.16%-151.3M | 91.27%-138.9M | -91.82%111.2M |
Net common stock issuance | ---- | 96.71%-7.8M | 97.89%-700K | 91.20%-7.1M | --0 | ---- | 16.08%-237M | 41.24%-33.2M | 14.51%-80.7M | -106.16%-97.1M |
Cash dividends paid | ---- | 1.77%-277.1M | 0.14%-69.3M | 1.14%-69.2M | 2.87%-138.6M | ---- | -5.42%-282.1M | -5.47%-69.4M | -4.79%-70M | -5.70%-142.7M |
Net other financing activities | ---- | 10,686.21%307M | --0 | ---- | 88.89%-100K | 307,200.00%307.1M | -101.58%-2.9M | 0.00%-800K | -100.59%-1.1M | -12.50%-900K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 2.77%-133.4M | 245.27%1.18B | 22.22%-198.1M | -21.53%-353.3M | 1,543.32%1.87B | 0.36%-137.2M | -388.26%-812.6M | -304.91%-254.7M | 81.45%-290.7M | -111.00%-129.5M |
Net cash flow | ||||||||||
Beginning cash position | -75.82%11.1M | -79.79%45.9M | -73.77%25.1M | -65.64%32.2M | -84.01%25.2M | -79.79%45.9M | 66.13%227.1M | -85.99%95.7M | -95.75%93.7M | -83.75%157.6M |
Current changes in cash | 350.24%51.8M | 80.79%-34.8M | 71.89%-14M | -455.00%-7.1M | 110.95%7M | 70.22%-20.7M | -300.44%-181.2M | 89.08%-49.8M | 100.13%2M | -105.17%-63.9M |
End cash Position | 149.60%62.9M | -75.82%11.1M | -75.82%11.1M | -73.77%25.1M | -65.64%32.2M | -84.01%25.2M | -79.79%45.9M | -79.79%45.9M | -85.99%95.7M | -95.75%93.7M |
Free cash from | 39.38%162.8M | 31.62%859.6M | -10.14%183.5M | 13.02%350.8M | 208.43%208.5M | 64.74%116.8M | 346.08%653.1M | 143.03%204.2M | 668.32%310.4M | -2.59%67.6M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.